Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Int J Tuberc Lung Dis ; 13(2): 190-5, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19146746

ABSTRACT

BACKGROUND: Treatment of latent tuberculosis (TB) infection (LTBI) in Brazil is recommended only in the case of contacts of pulmonary smear-positive TB patients agedor=10 mm and no previous bacille Calmette-Guérin (BCG) vaccination or with a TST>or=15 mm regardless of previous BCG vaccination. OBJECTIVE: To evaluate the 2-year incidence and predictors of TB among contacts who did not meet the Brazilian criteria for LTBI treatment. DESIGN: Retrospective cohort study. Contacts aged between 12 and 15 years and those aged>or=15 years who did not meet the Brazilian criteria for LTBI treatment were enrolled in the study. RESULTS: TB incidence was 3.2% (22/667), with an estimated TB rate of 1649 per 100000 population. Risk of TB was greater among the 349 contacts with TST>or=5 mm (5.4%) compared to the 318 contacts with TST<5 mm (0.9%; RR 6.04, 95%CI 1.7-20.6). CONCLUSION: The high incidence of TB among contacts who did not meet the Brazilian criteria for LTBI treatment strongly suggests that these criteria should be reviewed. Furthermore, even among BCG-vaccinated contacts, TST induration>or=5 mm was the only variable that predicted the development of TB disease within 2years.


Subject(s)
Carrier State/epidemiology , Disease Transmission, Infectious/statistics & numerical data , Tuberculosis, Pulmonary/epidemiology , Tuberculosis, Pulmonary/transmission , Adolescent , Adult , Antitubercular Agents/therapeutic use , Brazil , Carrier State/diagnosis , Cohort Studies , Disease Transmission, Infectious/prevention & control , Female , Humans , Incidence , Isoniazid/therapeutic use , Male , Middle Aged , Practice Guidelines as Topic , Predictive Value of Tests , Pyrazinamide/therapeutic use , Retrospective Studies , Rifampin/therapeutic use , Risk , Tuberculin Test , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL